On-Demand CLSI and CAP 2021 Webinar
Ensuring Quality Beyond the Test: Reporting Antimicrobial Susceptibility Results
This webinar was recorded on Thursday, January 21, 2021.
After this program, participants will be able to:
- Evaluate how to best report AST results on isolates recovered from the CSF.
- Describe best practices on reporting AST results for pan-susceptible isolates.
- Discuss strategies on how to best report results for antimicrobials with no breakpoints.
- Review impact of taxonomy changes on AST results.
Romney M. Humphries, PhD, (D)ABMM
Professor, Pathology, Microbiology and Immunology, and Medical Director, Clinical Microbiology, Vanderbilt University Medical Center
Tanis Dingle, PhD, FCCM, D(ABMM)
Clinical Microbiologist, Public Health Laboratory (ProvLab), Alberta Precision Laboratories (APL)
Assistant Professor, Laboratory Medicine and Pathology, University of Alberta
Carol Ann Rauch, MD, PhD, FCAP
Antibiotic Resistance Laboratory Network Technical Laboratory Liaison, Centers for Disease Control and Prevention
Adjunct Associate Professor of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine
Earn 1.0 PACE CE® Credit.
CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
Cost: $30.00 per person. Member discounts do not apply for this webinar.
Date of Webinar: January 21, 2021
On-Demand CLSI and CAP 2021 Webinar Additional Details
For information on CLSI’s education courses and webinar policies read here.